Specific References (2) | SL4529R has been referenced in 2 publications.
[IF=4.43] Wei, Ding, et al. "Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice."Journal of Experimental & Clinical Cancer Research 34.1 (2015): 1. IHSLCP ; Mouse.
[IF=3.24] Bo-Kyoung Jung. et al. The human ACE-2 receptor binding domain of SARS-CoSLV2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate. Plos One. 2022 Feb;17(2):e0263684 WB ; Monkey.